For RMD patients who are on immunosuppressive medication, deferring live-attenuated vaccines is conditionally recommended. For RMD patients, holding immunosuppressive medication for an appropriate period before (see JAK= Janus kinase; TNF=tumor necrosis factor; IL=interleukin; IVIG= intravenous immunoglobulin G; IV = intravenous a for patients taking the equivalent of prednisone < 20 mg/day or < 2 mg/kg/day for patients weighing < 10 kg, or alternate-day glucocorticoid therapy (i.e., "low level immunosuppression" (14, 68), these low doses can be continued if vaccination is critical and the risk of a disease flare or adrenal insufficiency off glucocorticoids is high. b for patients taking methotrexate ≤ 0.4 mg/kg/week or azathioprine ≤ 3 mg/kg/day ("low level" immunosuppression" (14, 68), hold times can be shortened if vaccination is critical and the risk of a disease flare off immunosuppression is high. c for medications with more than one FDA-approved dosing interval, the longest